Prefilled Syringes Market Size, Growth, Report By 2032

The global prefilled syringes market size reached USD 17.16 billion in 2023 and is expected to be worth around USD 46.09 billion by 2032, growing at a CAGR of 11.6% from 2023 to 2032.

Key Points:

Europe led the global market with the highest market share in 2022.
By Type, the safety prefilled syringes segment captured the biggest revenue share in 2022.
By Material, the glass prefilled syringes segment is estimated to hold the highest market share in 2022.
By Design, the single-chamber prefilled syringes segment has held the largest market share in 2022.

The prefilled syringes make injections accurate, easy, and safe for, both, doctors and patient. Pre-filled syringes have is one of the fastest- growing selection for the medication of unit dose, as the pharmaceutical industry seeks new and more accessible medicine delivery styles.

In addition, pharmaceutical companies can get benefit by saving the cost of vials. Pharmaceutical key players are suitable to minimize medicine waste and increase product life span, while patients are suitable to self- administer injectable medicines at their home rather of the hospital. In addition, re-filled syringes have also stayed employed across a wide range of therapeutic sectors, similar as blood instigations, vaccines, and remedial proteins.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1575

Excluding dosing errors and ease of use are two of the topmost advantages of pre-filled syringes. Accordingly, the discrimination advantages handed by prefilled syringes above traditional syringes are leading to the increased relinquishment and contributing to the global market growth.

Report Highlights

On the basis of type, the segment named safety prefilled syringes is anticipated to foresee the highest growth rate during the forthcoming time period primarily due to the growing elderly population worldwide and presence of the rapies of biological for patients suffering from chronic diseases alleviates some of the pressure on hospitals.
On the basis of material, the glass prefilled syringes segment accounted for the largest share of the prefilled syringes in 2020.
On the basis of design, the single- chamber prefilled syringes segment accounted for the largest share of the prefilled syringes market.
Europe is one of the major profit-generating regions in the market of prefilled syringes. Growing chronic diseases frequency, rise of the biosimilar and biologics market, geographical expansion by crucial manufacturers, growing population, technological advancements, and high adoption of self-injection equipment’s are boosting the demand for prefilled syringes which are self-injectable are the key factors boosting the growth of the prefilled syringes market in the European region.

Table of Contents

Report Scope of the Prefilled Syringes Market

Report Coverage	Details
Market Size by 2023	USD 17.16 Billion
Market Size by 2032	USD 46.09 Billion
Growth Rate from 2023 to 2032	CAGR of 11.6%
Base Year	2022
Largest Market	Europe
Fastest Growing Market	North America
Forecast Period	2023 to 2032
Segments Covered	Type, Material, Design, Product, Closing System, Application, End User, Region

Prefilled Syringes Market Dynamics

Driver: Rising target complaint population

Prefilled syringes are substantially used for the treatment of chronic diseases, similar as diabetes, heart conditions, and autoimmune conditions, which bear patients to self-administer specifics. As a result, the adding prevalence and frequency of chronic and life conditions across the globe is a major factor contributing to the growth of the prefilled syringes market. Also, there’s a growing demand for self-injection equipments, considering the convenience and safety associated with their use.

Restraint: Dearth of prefilled syringes with intertwined safety features

Prefilled syringes give better safety of patient by diminishing the potential for unintended needle sticks and poisonous products exposure that can do while drawing drug from vials. In similar patients, the defiled needle of prefilled syringes can lead to blood- borne infections, similar as HIV and HCV. In addition, the partial prefilled syringes market presence with intertwined safety features, due to their challenging and expensive manufacturing procedure, is a major concern in the market. Still, this trend is anticipated to change in the coming times, as the healthcare market is laying lesser emphasis on reducing the rate of needle stick injuries, which, in turn, is paving the way for the development of safety prefilled hypes.

Opportunity: Growing healthcare structure across arising markets

Emerging economies will continue to suffer from inadequate healthcare backing, which negatively affects access to quality, healthcare, and, eventually, the health status of citizens. According to the World Bank, roughly 400 million people lacks access to essential healthcare services, substantially in Africa and South Asia. Likewise, accelerating medical affectation, the cost of medical treatments and an advanced frequency of non-communicable life- related conditions similar as diabetes, cancer, or cardiac arrest, have rebounded in funding gaps.

According Geneva Association report, in the last 20 years, the share of the aggregate global healthcare expenditure in GDP has raised from about 8% to nearly 10%, or an estimated US$8000 billion per year, which is boosted by the expanding treatment options, medical treatment accelerating cost and adding client demands. Also, the Global Burden of Disease Health Financing Collaborator Network (2017) estimates that global spending on health will nearly triple to USD 24 trillion by 2040 with upper-middle- income countries are estimated to show the fastest increase at a normal of5.3% per time. This growth could be attributed to uninterrupted growth in GDP and the rise of the middle class and government spending.

Challenge: Availability of cheaper alternatives

Traditionally, injectable were painful and invasive in nature, which was the major concern for patients to prefer medicine delivery alternate routes, such as topical, oral, and nasal. In addition, among the various routes of medicine delivery, the oral route is the most preferred as it’s easy to use, accessible, cost-effective, safe, and respectable. Due to the above mentioned factors, the adoption of indispensable medicine delivery technologies is adding across the globe. Like, cost-effective delivery styles development for insulin, alternate, similar as Medtronic’s Veo insulin and Pfizer’s Exubera pump, is restraining the usage of injectable insulin. Presently, insulin is substantially administered via injections, and therefore, injections of insulin form a significant market for injectable medicine delivery technologies. Still, the arrival of inhalable insulin is anticipated to significantly impact the growth of this market as nasal medicine delivery is pain-free and largely patient-biddable.

Key Market Developments

In December 2020, Becton, Dickinson and Company (BD) to invest around USD 1.2 billion to expand its manufacturing technology and capacity of prefilled syringes. This strategy enhanced the company to create strong position in the market.
In March 2019, SCHOTT launched syriQBioPure that is world’s first lubricant free prefilled glass syringe. This innovative launch enabled the company to extend its product portfolio in this industry.

Some of the prominent players in the global prefilled syringes market include:

SCHOTT AG
West Pharmaceutical Services, Inc.
Baxter International Inc.
Weigao Group
Vetter Pharma International GmbH
Nipro Corporation
Elcam Medical
Oval Medical Technologies
SHL Medical AG
Terumo

Segments Covered in the Report

By Type

Conventional Prefilled Syringes
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
Safety Prefilled Syringes

By Material

Glass
Plastic

By Design

Single-Chamber
Dual- Chamber
Customized

By Product

Complete Syringe Set
Components and Accessories

By Application

Diabetes
Rheumatoid Arthritis
Anaphylaxis
Cancer
Thrombosis
Ophthalmology
Others

By Closing System

Staked Needle System
Luer Cone System
Luer Lock Form System

By End User

Pharmaceutical and Biotechnology Companies
Contract Research and Manufacturing Organizations
Others

By Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa